- Filed
- Jun 5, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding restated | Q1 2026 · May 7, 2026 | 104.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 101.45M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 101.82M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.87M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.9M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $3.14M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.58M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.24B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.18B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $276.95M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $340.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.17B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.16B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.1B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.08B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $9.84B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.86B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $11.01B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.02B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.13 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.09 |
| Net Income | Q1 2026 · Mar 31, 2026 | $13.1M |
| Net Income | Q1 2026 · Mar 31, 2025 | $8.9M |